摘要
Ultrasound neuromodulation is a potential alternative therapy for suppressing epileptic discharges. Recently, several human clinical trials have reported promising results from repeated focused ultrasound (FUS) treatments for temporal lobe epilepsy. In this Viewpoint, we highlight the valuable guidance of preclinical validation methods for choosing the optimal FUS parameters, thus ensuring consistency with the outcomes of clinical trials and leading human trials to the safest and most effective approaches.
| 原文 | 英語 |
|---|---|
| 頁(從 - 到) | 1728-1731 |
| 頁數 | 4 |
| 期刊 | ACS Chemical Neuroscience |
| 卷 | 15 |
| 發行號 | 9 |
| DOIs | |
| 出版狀態 | 已出版 - 01 05 2024 |
| 對外發佈 | 是 |
文獻附註
Publisher Copyright:© 2024 The Authors. Published by American Chemical Society.
指紋
深入研究「Neuromodulatory Focused Ultrasound for Epilepsy: Are Animal Models Useful?」主題。共同形成了獨特的指紋。引用此
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver